Summary
The interaction between glucagon and veratramine was studied in anesthetized vagotomized dogs and in heart-lung preparations from dogs. In both preparations, veratramine administered when maximal effects of an infusion of glucagon became manifest, reduced heart-rate to either control or near control levels. In both preparations glucagon increased myocardial contractile force, as gauged by the maximal rate of rise of left ventricular pressure, dp/dt, markedly, but subsequent administration of veratramine lowered dp/dt significantly only in the intact preparations in which a concomitant substantial decrease in mean arterial pressure was noted after glucagon with further decrease after veratramine. Pentobarbital-induced myocardial failure in heart-lung preparations was successfully corrected with an infusion of glucagon. Subsequent administration of veratramine reduced the glucagon-induced tachycardia to near control level without affecting myocardial contractility. It may be concluded from this study that veratramine blocks the chronotropic but not the inotropic action of glucagon, an effect which is reminiscent of its inhibitory action on the chronotropic but not the inotropic effect of the catecholamines, first demonstrated by Krayer.
Similar content being viewed by others
References
Farah, A., Tuttle, R.: Studies on the pharmacology of glucagon. J. Pharmacol. exp. Ther. 129, 49–55 (1960)
Glick, G., Parmley, W. W., Wechsler, A. S., Sonnenblick, E. H.: Glucagon: Its enhancement of cardiac performance in the cat and dog and dpersistence of its inotropic action despite beta-receptor blockade with propranolol. Circulat. Res. 22, 789–799 (1968)
Hawkins, D. F.: Studies on veratrum alkaloids. XXXIV. Actions of veratramine on spontaneously beating guinea-pig atrium preparations. J. Pharmacol. exp. Ther. 137, 306–312 (1962)
Krayer, O.: Veratramine an antagonist to the cardioaccelerator action of epinephrine. Proc. Soc. exp. Biol. (N.Y.) 70, 631–632 (1949a)
Krayer, O.: Studies on veratrum alkaloids. VIII. Veratramine, an antagonist to the cardio-accelerator action of epinephrine. J. Pharmacol. exp. Ther. 96, 422–437 (1949b)
Krayer, O.: Studies on veratrum alkaloids, XII. A quantitative comparison of the antiaccelerator cardiac action of veratramine, veratrosine, jervine and pseudojervine. J. Pharmacol. exp. Ther. 98, 427–436 (1950)
Krayer, O., Arora, R. B., Meilman, E.: Studies on veratrum alkaloids. XXI. The action of veratramine upon impulse generation in the dog heart. J. Pharmacol. exp. Ther. 113, 446–459 (1955)
Krayer, O., Van Maanen, E. F.: Studies on veratrum alkaloids. X. The inhibition by veratramine of the positive chronotropic effect of accelerans stimulation and of norepinephrine. J. Pharmacol. exp. Ther. 97, 301–307 (1949)
Langer, S. Z., Trendelenburg, U.: Studies on veratrum alkaloids. XXXIX. Interaction of veratramine and accelerating agents on the pacemaker of the heart. J. Pharmacol. exp. Ther. 146, 99–110 (1964)
Lucchesi, B. R.: Cardiac actions of glucagon. Circulat. Res. 22, 777–787 (1968)
Murnaghan, M. F.: The action of veratramine upon cardioacceleration caused by histamine and the xanthine alkaloids. Arch. int. Pharmacodyn. 134, 297–305 (1961)
Regan, T. J., Lehan, P. H., Henneman, D. H., Behar, A., Hellems, H. K.: Myocardial metabolic and contractile response to glucagon and epinephrine. J. Lab. clin. Med. 63, 638–647 (1964)
Simaan, J., Fawaz, G.: The metabolic effect of noradrenaline on the isolated canine heart after blockade of the chronotropic action by veratramine. Naunyn-Schmiedeberg's Arch. Pharmacol. 277, 199–209 (1973)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Fawaz, G., Simaan, J. Dissociation between the chronotropic and inotrophic actions of glucagon. Naunyn-Schmiedeberg's Arch. Pharmacol. 283, 293–301 (1974). https://doi.org/10.1007/BF00499189
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00499189